Last updated: February 26, 2021
Sponsor: The Central Hospital of Lishui City
Overall Status: Active - Recruiting
Phase
4
Condition
Kidney Disease
Nephropathy
Kidney Failure (Pediatric)
Treatment
N/AClinical Study ID
NCT04776187
Gadolinium 1.0
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients aged 18 to 80 years old who require gadolinium-based CE-MRI;
- Patients with renal function 30ml/min/1.73m2≤eGFR<90/min/1.73m2;
- Patients who are able and willing to comply with the required inspection requirements.
Exclusion
Exclusion Criteria:
- Patient who experienced allergic reactions to previous gadolinium-based contrastagents;
- Patient who had used gadolinium-based contrast agents within 3 months;
- Patient with acute renal failure;
- Patient who cannot comply with or cannot tolerate the necessary fluid replenishmentprocedures;
- Patient with major mental illness, impaired consciousness, or other diseasesconsidered by researchers to affect observation.
Study Design
Total Participants: 600
Study Start date:
March 01, 2021
Estimated Completion Date:
December 31, 2021
Study Description
Connect with a study center
Lishui Central Hospital
Lishui, Zhejiang 323000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.